Drug profile · INN
flurandrenolide
CORDRAN N
flurandrenolide (CORDRAN N) is a glucocorticoid receptor agonist. Associated with Almirall, S.A.. Route of administration: topical. Current US regulatory status: approved.
Drug details — flurandrenolide
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 20
- Programs
- 0
- Data quality
- 0.89
Quick answer
flurandrenolide (CORDRAN N) is a glucocorticoid receptor agonist. Associated with Almirall, S.A.. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12414911
Topical compositions and methods of use
granted -
US 12412764
Substrate-accommodating container
granted -
US 12280142
Compositions for preventing infection
granted -
US 12239684
Modulators of complement activity
granted -
US 12103978
Methods and materials for treating cancer
granted -
US 12012468
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11932705
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11890225
Devices and methods for slurry generation
granted -
US 11882920
Systems, devices and methods for styling hair
granted -
US 11814445
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11814444
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11795130
Process for separating a constituent/cannabinoid using a chromatographic resin
granted -
US 11723949
Modulators of complement activity
granted -
US 11707503
Modulators of complement activity
granted -
US 11530244
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11505575
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11439532
Point of delivery cold slurry generation
granted -
US 11324673
Cosmetic appearance of skin
granted -
US 11123399
Modulators of complement activity
granted -
US 11000409
Devices and methods for slurry generation
granted
Frequently asked questions
What is flurandrenolide?
flurandrenolide (CORDRAN N) is a glucocorticoid receptor agonist. Associated with Almirall, S.A.. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for flurandrenolide?
CORDRAN N is a marketed brand name for flurandrenolide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of flurandrenolide?
flurandrenolide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.